In this article

NOVO.B-DK

Follow your favorite stocks CREATE FREE ACCOUNT

Novo Nordisk on Monday said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price, as drugmakers face mounting political pressure to lower prices in the country.

Patients can pay $499 in cash per month for three dose sizes of Ozempic. They can get the price through platforms including the drug's official website, Novo Nordisk's patient assistance program and the company's recently launched direct-to-consumer online pharmacy , the latter of which also ships the injection directly to patients' homes.

Drug savings company GoodRx will also offer Ozempic and its weight loss counterpart Wegovy for $499 per month, making the discounts av

See Full Page